Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chemocentryx Inc (CCXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 484,120
  • Shares Outstanding, K 58,048
  • Annual Sales, $ 42,880 K
  • Annual Income, $ -37,970 K
  • 60-Month Beta 1.37
  • Price/Sales 11.75
  • Price/Cash Flow N/A
  • Price/Book 6.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.21
  • Number of Estimates 6
  • High Estimate -0.13
  • Low Estimate -0.27
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.06 +7.69%
on 06/05/19
12.50 -30.56%
on 05/29/19
-3.75 (-30.17%)
since 05/17/19
3-Month
8.06 +7.69%
on 06/05/19
14.98 -42.06%
on 04/05/19
-1.51 (-14.82%)
since 03/15/19
52-Week
8.06 +7.69%
on 06/05/19
14.98 -42.06%
on 04/05/19
-3.85 (-30.73%)
since 06/15/18

Most Recent Stories

More News
SmarTrend Watching for Potential Rebound in Shares of Corning Inc After 2.68% Loss

Corning Inc (NYSE:GLW) traded in a range yesterday that spanned from a low of $30.30 to a high of $31.99. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $30.91 on...

GLW : 31.43 (+1.68%)
CCXI : 8.71 (+4.44%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (VNDA , LXRX , CCXI , MYGN , ALXN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LXRX : 5.92 (+4.78%)
VNDA : 14.67 (+0.48%)
CCXI : 8.71 (+4.44%)
ChemoCentryx to Present at Two Upcoming Investor Conferences

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences in June:

CCXI : 8.71 (+4.44%)
Downtrend Call Working As Chemocentryx Inc Stock Falls 33.5% (CCXI)

SmarTrend identified a Downtrend for Chemocentryx Inc (NASDAQ:CCXI) on April 15th, 2019 at $12.97. In approximately 2 months, Chemocentryx Inc has returned 33.51% as of today's recent price of $8.62.

CCXI : 8.71 (+4.44%)
Chemocentryx Inc Set to Possibly Rebound After Yesterday's Selloff of 3.46%

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $8.48 to a high of $8.89. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $8.58...

CCXI : 8.71 (+4.44%)
ChemoCentryx (CCXI) Moves to Buy: Rationale Behind the Upgrade

ChemoCentryx (CCXI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CCXI : 8.71 (+4.44%)
ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates

ChemoCentryx (CCXI) delivered earnings and revenue surprises of 4.17% and -26.74%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CCXI : 8.71 (+4.44%)
ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights

-- Succession of topline data readouts expected, starting with Pivotal ADVOCATE Phase III trial of C5a receptor inhibitor avacopan in ANCA Vasculitis in Q4 2019 --

CCXI : 8.71 (+4.44%)
Chemocentryx Inc Rises 2.82% on Heavy Volume: Watch For Potential Pullback

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $13.16 to a high of $13.59. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high...

CCXI : 8.71 (+4.44%)
ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's first quarter 2019 financial results will be released after market close on Monday, May 6, 2019. ChemoCentryx executive management...

CCXI : 8.71 (+4.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CCXI with:

Business Summary

ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.

See More

Key Turning Points

2nd Resistance Point 8.90
1st Resistance Point 8.62
Last Price 8.71
1st Support Level 8.19
2nd Support Level 8.04

See More

52-Week High 14.98
Fibonacci 61.8% 12.34
Fibonacci 50% 11.52
Fibonacci 38.2% 10.70
Last Price 8.71
52-Week Low 8.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar